CSF cell-free DNA EGFR testing using DdPCR holds promise over conventional modalities for diagnosing leptomeningeal involvement in patients with non-small cell lung cancer-Reference-Cited by-同舟云学术

CSF cell-free DNA EGFR testing using DdPCR holds promise over conventional modalities for diagnosing leptomeningeal involvement in patients with non-small cell lung cancer

Published:2020-10 Issue: Volume:148 Page:33-39
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Suryavanshi Moushumi,Jaipuria Jiten,Panigrahi Manoj Kumar,Goyal Neha,Singal Rishu,Mehta Anurag,Batra Ullas,Doval D.C.,Talwar Vineet

Funder

Rajiv Gandhi Cancer Institute and Research center, Delhi. India

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference30 articles.

1. Lyon: World Health Organization International Agency for Research on Cancer;GLOBOCAN,2018

2. US National Institute of Health, National Cancer Institute, SEER Cancer Statistics Review, 1975–2015.

3. Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancers;Rangachari;Lung Cancer,2015

4. High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib;Omuro;Cancer,2005

5. Leptomeningeal metastases in patients with NSCLC with EGFR mutations;Li;J. Thorac. Oncol.,2016

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cerebrospinal fluid: A unique source of circulating tumor DNA with broad clinical applications;Translational Oncology;2023-07

2. Efficacy of different platforms in detecting EGFR mutations using cerebrospinal fluid cell‐free DNA from non‐small‐cell lung cancer patients with leptomeningeal metastases;Thoracic Cancer;2023-03-28

3. Early Detection of Leptomeningeal Metastases Among Patients Undergoing Spinal Stereotactic Radiosurgery;Advances in Radiation Oncology;2023-03

4. Prognosticators of osimertinib treatment outcomes in patients with EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis;Journal of Cancer Research and Clinical Oncology;2022-11-01

5. Transcending Blood—Opportunities for Alternate Liquid Biopsies in Oncology;Cancers;2022-03-03